<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou Y</submitter><funding>NCI NIH HHS</funding><pagination>7904-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2867889</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>107(17)</volume><pubmed_abstract>MicroRNAs (miRNAs) are noncoding RNAs that regulate global gene expression. miRNAs often act synergistically to repress target genes, and their dysregulation can contribute to the initiation and progression of a variety of cancers. The clinical relationship between global expression of miRNA and mRNA in cancer has not been studied in detail. We used whole-genome microarray analyses of CD138-enriched plasma cells from 52 newly diagnosed cases of multiple myeloma to correlate miRNA expression profiles with a validated mRNA-based risk stratification score, proliferation index, and predefined gene sets. In stark contrast to mRNAs, we discovered that all tested miRNAs were significantly up-regulated in high-risk disease as defined by a validated 70-gene risk score (P &lt; 0.01) and proliferation i</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.</pubmed_title><pmcid>PMC2867889</pmcid><funding_grant_id>CA55819</funding_grant_id><funding_grant_id>P01 CA055819</funding_grant_id><pubmed_authors>Stephens O</pubmed_authors><pubmed_authors>Waheed S</pubmed_authors><pubmed_authors>Williams DR</pubmed_authors><pubmed_authors>Barlogie B</pubmed_authors><pubmed_authors>Anaissie E</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Pineda-Roman M</pubmed_authors><pubmed_authors>Shaughnessy JD</pubmed_authors><pubmed_authors>Alsayed Y</pubmed_authors><pubmed_authors>Cartron MA</pubmed_authors><pubmed_authors>Nair B</pubmed_authors><pubmed_authors>van Rhee F</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.</name><description>MicroRNAs (miRNAs) are noncoding RNAs that regulate global gene expression. miRNAs often act synergistically to repress target genes, and their dysregulation can contribute to the initiation and progression of a variety of cancers. The clinical relationship between global expression of miRNA and mRNA in cancer has not been studied in detail. We used whole-genome microarray analyses of CD138-enriched plasma cells from 52 newly diagnosed cases of multiple myeloma to correlate miRNA expression profiles with a validated mRNA-based risk stratification score, proliferation index, and predefined gene sets. In stark contrast to mRNAs, we discovered that all tested miRNAs were significantly up-regulated in high-risk disease as defined by a validated 70-gene risk score (P &lt; 0.01) and proliferation i</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Apr</publication><modification>2026-05-05T06:16:56.432Z</modification><creation>2026-04-07T21:24:35.736Z</creation></dates><accession>S-EPMC2867889</accession><cross_references><pubmed>20385818</pubmed><doi>10.1073/pnas.0908441107</doi></cross_references></HashMap>